UNS 0.00% 0.5¢ unilife corporation

What does Amgen see in UNS, page-3

  1. 15 Posts.
    I think this is mostly holders who are just tired of seeing it drop every day and are cutting losses. We are getting close to pure capitulation at this point. At least the last time this happened we had the promise of the Amgen deal on the horizon. Right now we have almost nothing, other than an expectation of an announcement of some new management brought on. But will that even create a log term up trend of the SP? I doubt it. The only thing that will do that, IMO, is a steady increase in sales. A little visibility into the plan for profitability would be key as well. Is Abbvie still in play? Whats happening with the PFS deals with Hikma and Sanofi? Until these questions are answered, there is no bottom. That said, I've been buying back in as this slides because it seems like there is always some unknown that gets announced that spikes the SP. I just hope new management finds a way to be more transparent with the inner workings of the company. We don't even know the current production line capacity! This stock is a huge gamble still, but I, and I think most of us, are still in it because there could be a huge long term upside. Even if just the Hikma and Sanofi PFS deals come to their minimum values for exclusivity, and some minor wearable and AI sales, this could be a Disallowed in 5 years, again, all in my opinion. DYOR!
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.